Search results for: Precision Medicine
Filter search results
Patterns of European Diagnoses and Prescribing
1 January 1984
In the summer of 1982 the Medico-Pharmaceutical Forum held a meeting on ‘Disparities in European Medicine’. The aim was to compare and contrast the various aspects of health and medical…
Achieving Accelerated Patient Access to Cancer Care in Europe
3 November 2025
Share this: Download publication George Bray Martina Garau Patricia Cubi-Molla Lotte Steuten Adrian Towse Key takeaways In recent years, the European Medicines Agency (EMA) has introduced a number of accelerated…
Dr. Jacoline Bouvy
19 March 2024
Dr. Jacoline Bouvy is the Programme Director of Medicines Evaluation at the National Institute for Health and Care Excellence (NICE). She is responsible for the delivery of medicines guidance produced…
Can a continued focus on prevention, diagnosis, and treatment see the NHS to another 75 years?
27 July 2023
…BCG vaccination program, the use of chest radiology and sputum examination, and the availability and use of new medicines. This highlighted how the NHS could improve health through PREVENTION, DETECTION…
Update: Value-Based Pricing in the UK
11 January 2011
Value-based pricing for new medicines, proposed as part of UK health care reform, would create a QALY-plus approach for drugs approved starting 1 January 2014. For new drugs, this would…
Differential Pricing – A Win-Win Solution?
2 March 2011
…higher prices have been established elsewhere’ thus delaying access by patients to new medicines. In extreme cases, companies may decide to not market a medicine at all in a particular…
Value-Based Pricing: OHE Comments
23 March 2011
In December 2010, the UK Department of Health released a consultation document to elicit comments on ‘proposals for a new value-based system of pricing medicines which aims to recognise and…
Does Relative Effectiveness Vary Across Europe?
9 August 2011
At the Spanish Health Economics Association (AES) conference in May 2011, OHE’s Ruth Puig Peiró discussed a recent OHE study that reviewed the available literature on variations in medicines’ efficacy…
Guidelines for the Economic Evaluation of Pharmaceuticals: Can the UK learn from Australia and Canada?
1 May 1997
…introducing rigorous guidelines and (in Australia and Ontario) a formal requirement for studies to assess the cost effectiveness of new medicines. A number of issues arise for the UK. Some…